Search

Your search keyword '"Owera, A."' showing total 122 results

Search Constraints

Start Over You searched for: Author "Owera, A." Remove constraint Author: "Owera, A."
122 results on '"Owera, A."'

Search Results

1. Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

2. Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA)

3. A Study of Algebraic Curves in Neutrosophic Real Ring R(I) by Using the One-Dimensional Geometric AH-Isometry

4. The influence of anastomotic techniques on postoperative anastomotic complications: Results of the Oesophago-Gastric Anastomosis Audit

5. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA)

7. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma: An International Cohort Study From the Oesophagogastric Anastomosis Audit (OGAA)

8. A Study of Algebraic Curves in Neutrosophic Real Ring R(I) by Using the One-Dimensional Geometric AH-Isometry

9. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

11. Postoperative outcomes in oesophagectomy with trainee involvement

12. TH5.9 Role of Ultrasound in Management of Acute Appendicitis

14. Textbook outcome following oesophagectomy for cancer: international cohort study

16. Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

18. Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation

19. Postoperative and Pathological Outcomes of CROSS and FLOT as Neoadjuvant Therapy for Esophageal and Junctional Adenocarcinoma

21. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

22. Postoperative outcomes in oesophagectomy with trainee involvement

23. Postoperative outcomes in oesophagectomy with trainee involvement

26. Extended Characterization of Newly Diagnosed Multiple Myeloma (NDMM) Patients with In-Class Transition (iCT) from Parenteral Bortezomib to Oral Ixazomib Proteasome Inhibitor (PI) Therapy in the Community-Based United States (US) MM-6 Study: Updated Efficacy and Safety, and Reasons for Premature Discontinuation

29. A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors

30. Emergency Laparoscopic Splenectomy for Splenic Trauma in a Jehovah's Witness Patient

31. Timing of Laparoscopic Cholecystectomy for Acute Cholecystitis: Evidence to Support a Proposal for an Early Interval Surgery

32. Effect of Cercospora zeae-maydis infested maize residue on progress and spread of grey leaf spot of maize in central Uganda

33. Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma

34. Laparoscopic Enterolithotomy for Gallstone Ileus

37. Characterization and Partial Purification of Human Monoamine Oxidase-B Expressed inEscherichia coli

39. Laparoscopic endogastric and transgastric cystgastrostomy and pancreatic necrosectomy

40. A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM)

41. Laparoscopic versus open splenectomy for massive splenomegaly: a comparative study

42. Laparoscopic gastric and biliary bypass: a single-center cohort prospective study

43. Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study.

50. High incidence of hypersensitivity reactions to cetuximab infusions in mid-Missouri: Association with prior history of atopy

Catalog

Books, media, physical & digital resources